LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for tough skin cancers
Disease control OngoingThis study tests whether combining radiation therapy with the immunotherapy drug cemiplimab can help people with a type of advanced skin cancer called cutaneous squamous cell carcinoma that cannot be removed by surgery. About 34 participants will receive this treatment to see if …
Matched conditions: LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:25 UTC
-
New hope for transplant patients with skin cancer: RP1 trial launches
Disease control OngoingThis study tests a drug called RP1, which is injected directly into skin cancer tumors. It is for people who have had an organ or stem cell transplant and now have advanced skin cancer. The goal is to see if RP1 can shrink tumors safely without harming the transplanted organ. Abo…
Matched conditions: LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated May 26, 2026 08:19 UTC